相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer
Yasutsuna Sasaki et al.
CANCER SCIENCE (2014)
miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer
Dingzhi Huang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
A. Gutierrez-Gonzalez et al.
APOPTOSIS (2013)
Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel
Hao Wu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
Longlong Bao et al.
CANCER LETTERS (2013)
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
X. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Inhibition of Nuclear Factor-kappa B Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
Koichiro Haruki et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients
Hao Huang et al.
MEDICAL ONCOLOGY (2013)
miR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-Induced Apoptosis in Gastric Adenocarcinoma Cells
Xue Liu et al.
PLOS ONE (2013)
miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
Shou-mei Yang et al.
TOXICOLOGY (2013)
Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
Shuling Huang et al.
CANCER LETTERS (2012)
Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy
Takayuki Ando et al.
GASTRIC CANCER (2012)
Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine
Jingwei Yu et al.
MEDICAL ONCOLOGY (2012)
Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
Hyung Gyun Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Src family kinases and paclitaxel sensitivity
Xiao-Feng Le et al.
CANCER BIOLOGY & THERAPY (2011)
A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells
Hong Qiu et al.
CANCER LETTERS (2011)
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
Yu Ren et al.
BMC CANCER (2010)
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
Yan-jun Mi et al.
CANCER RESEARCH (2010)
MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
Zhimin Li et al.
GYNECOLOGIC ONCOLOGY (2010)
Origins and Mechanisms of miRNAs and siRNAs
Richard W. Carthew et al.
CELL (2009)
Multidrug Resistance Through the Spectacle of P-Glycoprotein
Katalin Goda et al.
CURRENT CANCER DRUG TARGETS (2009)
Hyaluronan-CD44 Interaction with Protein Kinase Cε Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
Yu-Zhuo Pan et al.
MOLECULAR PHARMACOLOGY (2009)
Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein
Denis Selimovic et al.
CELLULAR SIGNALLING (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
Zhiyu Zhang et al.
LABORATORY INVESTIGATION (2008)
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Olga Kovalchuk et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Biological principles of microRNA-mediated regulation: shared themes amid diversity
Alex S. Flynt et al.
NATURE REVIEWS GENETICS (2008)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Multiple genetic and epigenetic interacting mechanisms' contribute to clonally selection of drug-resistant tumors: Current views and new therapeutic prospective
A Roberti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
Fanyin Meng et al.
GASTROENTEROLOGY (2006)
P-glycoprotein - Implications of metabolism of neoplastic cells and cancer therapy
A Breier et al.
CURRENT CANCER DRUG TARGETS (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
